145 related articles for article (PubMed ID: 15803099)
21. A transesterification reaction is implicated in the covalent binding of benzo[b]acronycine anticancer agents with DNA and glutathion.
David-Cordonnier MH; Laine W; Kouach M; Briand G; Vezin H; Gaslonde T; Michel S; Doan Thi Mai H; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Bioorg Med Chem; 2004 Jan; 12(1):23-9. PubMed ID: 14697766
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activity of esters in the trans-1,2-dihydroxy-1,2-dihydroacronycine series.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
J Nat Prod; 1998 Feb; 61(2):198-201. PubMed ID: 9514007
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic activity of acronycine analogues in the benzo[c]pyrano[3,2-h]acridin-7-one and naphtho[1,2-b][1,7] and [1,10]-phenanthrolin-7(14H)-one series.
Bongui JB; Elomri A; Cahard D; Tillequin F; Pfeiffer B; Pierré A; Seguin E
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1540-6. PubMed ID: 16327185
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxic activity of dimeric analogs of acronycine in the benzo[b]pyrano[3,2-h]acridin-7-one series.
Gaslonde T; Michel S; Koch M; Pfeiffer B; Léonce S; Pierré A; Tillequin F
Chem Pharm Bull (Tokyo); 2007 May; 55(5):734-8. PubMed ID: 17473459
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, cytotoxic activity, and mechanism of action of furo[2,3-c]acridin-6-one and benzo[b]furo[3,2-h]acridin-6-one analogues of psorospermin and acronycine.
Boutefnouchet S; Gaboriaud-Kolar N; Nguyen TM; Depauw S; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A; Tillequin F; Lallemand MC; Michel S
J Med Chem; 2008 Nov; 51(22):7287-97. PubMed ID: 18947222
[TBL] [Abstract][Full Text] [Related]
27. 1-Oxo-2-hydroxy-1,2-dihydroacronycine: a useful synthon in the acronycine series for the introduction of amino substituents at 6-position and for the conversion into isopropylfuroacridones.
Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1304-7. PubMed ID: 11605659
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
Sittisombut C; Boutefnouchet S; Trinh Van-Dufat H; Tian W; Michel S; Koch M; Tillequin F; Pfeiffer B; Pierré A
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1113-8. PubMed ID: 16880654
[TBL] [Abstract][Full Text] [Related]
29. Syntheses and biological evaluation of vinblastine congeners.
Kuehne ME; Bornmann WG; Markó I; Qin Y; LeBoulluec KL; Frasier DA; Xu F; Mulamba T; Ensinger CL; Borman LS; Huot AE; Exon C; Bizzarro FT; Cheung JB; Bane SL
Org Biomol Chem; 2003 Jun; 1(12):2120-36. PubMed ID: 12945903
[TBL] [Abstract][Full Text] [Related]
30. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
31. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
[TBL] [Abstract][Full Text] [Related]
32. Vinorelbine (Navelbine): a third-generation vinca alkaloid.
Budman DR
Cancer Invest; 1997; 15(5):475-90. PubMed ID: 9316630
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine.
Tian W; Yougnia R; Depauw S; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A; Dufat H; Michel S
J Med Chem; 2014 Dec; 57(24):10329-42. PubMed ID: 25360689
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
[TBL] [Abstract][Full Text] [Related]
35. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
37. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
38. Syntheses of 5a'-homo-vinblastine and congeners designed to establish structural determinants for isolation of atropisomers.
Kuehne ME; Cowen SD; Xu F; Borman LS
J Org Chem; 2001 Aug; 66(16):5303-16. PubMed ID: 11485449
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine.
Dheyongera JP; Geldenhuys WJ; Dekker TG; Van der Schyf CJ
Bioorg Med Chem; 2005 Feb; 13(3):689-98. PubMed ID: 15653336
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
Nguyen TM; Sittisombut C; Boutefnouchet S; Lallemand MC; Michel S; Koch M; Tillequin F; Mazinghien R; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A
J Med Chem; 2006 Jun; 49(11):3383-94. PubMed ID: 16722658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
